Dynamic contrast-enhanced imaging has limited added value over T2-weighted imaging and diffusion-weighted imaging when using PI-RADSv2 for diagnosis of clinically significant prostate cancer in patients with elevated PSA
2016 ◽
Vol 34
(7)
◽
pp. 839-845
◽
2012 ◽
Vol 53
(12)
◽
pp. 830
◽
2018 ◽
Vol 48
(4)
◽
pp. 1012-1023
◽
2018 ◽
Vol 49
(3)
◽
pp. 864-874
◽